Submitted by Anonymous (not verified) on 9 November 2023 - 14:07
Human medicines European public assessment report (EPAR): Silodosin Recordati, silodosin, Prostatic Hyperplasia, Date of authorisation: 07/01/2019, Revision: 2, Status: Authorised
Source:
